- Global Pharma News & Resources

Anti-Hypertensive Drugs And Therapeutics Market: Rising Impressive Business Opportunities Analysis Forecast by 2028

Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. Hypertension arises when diastolic and systolic pressure persistently reaches or is above the 140/90mm Hg level. Moreover, hypertension is mainly caused due to change in lifestyle habits such as diet, smoking and alcohol intake. The anti-hypertensive drugs play important role in the treatment of high blood pressure, hypertension in patients.

To get more insights, visit:

High incidence of hypertension, and elevation in stress levels among young population are key factors driving the anti-hypertensive drugs and therapeutics market. In addition, changing lifestyle, food habits, and increasing awareness among individuals about hypertension and antihypertensive drugs are major factors contributing to growth of the global anti-hypertensive drugs and therapeutics market.

The global anti-hypertensive drugs and therapeutics market report has been segmented on the basis of therapeutics, and region. Region covered North America, Europe, Latin America, Middle East & Africa, and Asia Pacific.

Global anti-hypertensive drugs and therapeutics market segmentation by therapeutics:

  • Diuretics
  • Angiotensin receptor blockers (ARBs)
  • Angiotensin converting enzyme (ACE) inhibitors
  • Beta blockers
  • Alpha blockers
  • Calcium channel blockers
  • Renin inhibitors
  • Vasodilators

To Get Sample Copy of Report visit @

Currently, the market in North America dominates the global anti-hypertensive drugs and therapeutics market in revenue terms owing to increasing incidence of hypertension and existence of a large patient pool. Europe is currently the second-largest market due to increasing awareness among general population, and presence of a large geriatric population. The market in Asia Pacific is expected to witness relatively high growth over the forecast period owing to high incidences of cardiovascular diseases, improving healthcare infrastructure, and increasing government funding for R&D in the region.

Some prominent players in the global antihypertensive drugs and therapeutics market include, Pfizer Inc., Novartis AG, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Ranbaxy Laboratories Limited, Inc.

Editor Details

Last Updated: 14-Feb-2019